TAG: "Administration"

New contract reached for residents at UCSF Benioff Children’s Hospital Oakland


Agreement benefits physicians and patients.

UCSF Benioff Children’s Hospital Oakland and the Committee of Interns and Residents (CIR/SEIU Healthcare) have announced a contract settlement that recognizes the importance of the 91 resident physicians to the hospital and their role in furthering the hospital’s goal of providing unsurpassed care to children throughout the Bay Area.

“UCSF Benioff Children’s Hospital Oakland values our mission of educating physicians-in-training to become the next generation of pediatric caregivers,” says Dr. Bertram Lubin, president and CEO of UCSF Benioff Children’s Hospital Oakland. “We are pleased to have reached an agreement that further enables our residents to become outstanding pediatricians and pediatric sub-specialists in our community.”

The Committee of Interns and Residents voted and approved the contract, which will be in effect until May 2016. The agreement doubles the educational allowance for resident physicians and provides an additional subsidy to help cover the cost of the Board Exams that residents must take in their final year of residency. The educational allowance, which residents use to pay for books, conferences and electronic devices, will be increased from $500, $550 and $600 for first, second and third year residents to $1,000, $1,100 and $1,200, respectively through May 2016. The contract also provides a $500 ratification bonus to all residents. At the same time, the agreement takes into consideration the hospital’s need to be fiscally responsible in this challenging health care environment.

The residents’ union and the hospital also agreed to reassign an existing fund operated by the CHO Foundation to be used as a Patient Care Fund. The fund, which currently contains $93,000, can be used to purchase discharge medications and equipment based on needs identified by the resident physicians.

“It has been a difficult journey, but my fellow co-workers and I have certainly gained an understanding of the bargaining process and the importance of standing together,” said Dr. Ana Liang, a third-year resident and member of the CIR bargaining committee. “With the ratification of this new contract, I hope we continue to build upon our strengths as a residency program and as an institution bringing world class care to the children of Oakland.”

Both sides said they are gratified with the results and are looking forward to collaborating on advocacy efforts to protect Alameda County’s safety net hospitals and to improve the health of the community.

Media contacts:
Melinda Krigel, UCSF Benioff Children’s Hospital Oakland
(510) 428-3069

Heather Appel, CIR/SEIU Healthcare
(917) 886-3651

View original article

CATEGORY: NewsComments Off

Chancellor highlights UCSF’s strengths in era of change


Sam Hawgood recognizes UCSF community in inaugural State of the University.

UCSF Chancellor Sam Hawgood shares a laugh with Andre Campbell and Elizabeth Ozer after delivering his inaugural State of the University address at UCSF today (Sept. 30).

UCSF is poised at “a key inflection point” in its history and must be prepared to swing in new directions, Chancellor Sam Hawgood, M.B.B.S., said in his inaugural State of the University speech.

Hawgood addressed a packed auditorium in Cole Hall today (Sept. 30). The audience included nearly 80 past chancellors award winners whom Hawgood recognized to much applause.

Hawgood lauded UCSF for its unwavering support of basic science, its dedication to cultivating the best education and patient care, and its many successes at merging biology and technology in ways that are revolutionizing health.

“To thrive, we will need to be receptive to change and willing to swing in new directions while remaining true to our essential values – no small challenge to get right,” he said.

Hawgood noted that as the university celebrates its 150th anniversary this year, it is “at a hinge of history.” To continue to excel, he said, the university must adapt to changing funding situations and a new era of health and education with advances of technology.

As a 32-year member of the UCSF family, Hawgood said he’s honored to lead UCSF into this next phase in history – marked by new ways of teaching in a digital world, closer ties with the community that surrounds UCSF, and unprecedented levels of teamwork in health care delivery.

“Today, UCSF is a $4.9 billion enterprise. Despite significant stresses for all our community during a recessionary period, this represents more than 50 percent growth in our operating budget over the last seven years,” Hawgood said.

UCSF’s endowment also reached an all-time high in 2014 but it still falls far short of peer private institutions. Hawgood said he will make growing this endowment a high priority.

Earlier this year, the National Institutes of Health funding report showed that UCSF was the top public recipient of competitive grants in 2013, with all four professional schools leading the nation in their respective fields. Hawgood noted this underscores the extraordinary faculty and is also a testament to the vision of previous chancellors, ”who saw the opportunity, measured the risk, and built the world-class facilities that enabled this growth.”

Despite UCSF’s banner growth, Hawgood noted that the university is facing a substantive and probably long-term change in funding streams.

Federal funding accounts for more than 40 percent of UCSF’s nearly $5 billion budget, yet federal funding for research has fallen 22 percent over the last decade. State funding has declined as well, and now represents less that 10 percent of the budget.

Hawgood said as the research and education funding shifts across the nation, “helping define and execute well new external partnerships and relationships across all our missions will be a priority of my chancellorship.” And these partnerships will help UCSF more directly translate new knowledge into human good, he said.

Hawgood mentioned several exciting new partnerships already under way, including UCSF’s work with Google to create an online platform to enable health workers around the world predict where malaria is likely to be transmitted. The project uses data from the Google Earth Engine and works to enable resource-poor countries to wage more targeted strategies against the mosquito-born disease, which kills 600,000 people a year.

UCSF is also capitalizing on the strength of the University of California through a new tri-institutional partnership among UC Berkeley, Lawrence Berkeley National Laboratory and UCSF, he said. “This new alliance will catalyze bold, potentially transformative and collaborative science and technology initiatives among the three partners, beginning with genomics, imaging, and super-computing.”

This year also saw a new clinical partnership as UCSF and the Children’s Hospital Oakland came together to create the UCSF Benioff Children’s Hospitals. This affiliation rivals the best children’s hospitals in the country and provides safety net services to some of the most underserved families in our community.

“These and other partnerships in place or in the planning stages, if done right, will help define UCSF’s distinctiveness and serve to help attract the brightest of faculty and students to our campus,” Hawgood said.

Read more

For more health news, visit UC Health, subscribe by email or follow us on Flipboard.

CATEGORY: NewsComments Off

UCSF appoints interim medical school dean


Bruce Wintroub, previously vice dean, has served UCSF for more than 32 years.

Bruce Wintroub, UC San Francisco

Bruce Wintroub, M.D., has been named interim dean of the UCSF School of Medicine while a search committee looks for a permanent replacement. Chancellor Sam Hawgood, M.B.B.S., made the announcement today (Sept. 11).

“I am deeply grateful to Bruce for his dedicated service and commitment to lead the School through this transition period,” said Hawgood, who served as dean of the School of Medicine until Wintroub’s appointment. “I am confident that he is well equipped to serve in this role and to ably steer the school through the months ahead.”

Wintroub has served UCSF for more than 32 years. Most recently he has served as vice dean of the School of Medicine, a position he held for 10 years. Wintroub is also a professor and has been chair of the Department of Dermatology since 1985.

“I am delighted, honored and privileged to serve in this capacity for the School of Medicine and UCSF,” he said. “I deeply appreciate the trust and confidence the chancellor has in me.”

Wintroub will maintain his responsibilities in the Department of Dermatology, including his position as chair.

He also has led the Dermatology Foundation, a nonprofit organization that develops and retains tomorrow’s teachers and researchers in dermatology. Wintroub has helped raise more than $60 million for the organization.

He earned a bachelor’s degree at Amherst College in Amherst, Massachusetts, and a medical degree at Washington University in St. Louis, Missouri. Wintroub completed residencies and fellowships at Peter Bent Brigham Hospital (internal medicine) and Harvard Medical School (immunology and dermatology) and was a member of the Harvard Medical School faculty for six years before joining UCSF in 1982.

A search committee, co-led by Catherine Lucey, M.D., vice dean for education in the School of Medicine, and Shaun Coughlin, M.D., Ph.D., director of the Cardiovascular Research Institute, has been charged to make recommendations to find a permanent School of Medicine dean.

View original article

CATEGORY: NewsComments Off

Innovation center names executive director


Karyn DiGiorgio to lead systemwide center.

Karyn DiGiorgio

Karyn DiGiorgio, M.S.N., R.N., has been appointed executive director of the UC Center for Health Quality and Innovation (CHQI).

The center, based at the UC Office of the President, is a systemwide effort launched in 2010 to support innovative grants and spread best practices that aim to improve quality, increase efficiencies and reduce costs at UC medical centers.

DiGiorgio joined UCOP in 2013 as the associate director of CHQI, after working for the Gordon and Betty Moore Foundation, where she was a program officer in the Betty Irene Moore Nursing Initiative.

“Karyn brings a wealth of experience to this position, having served as associate director since 2013,” said Dr. John Stobo, UC Health senior vice president. “Karyn also served as interim director since March of 2014 following the retirement of Terry Leach, and has helped to enhance the scope of the center’s mission, collaborating with UCOP and medical center leadership to develop and implement a variety of patient care and revenue models as well as systemwide reimbursement models that will support UC Health’s Leveraging Scale for Value initiative.”

UC Health launched its Leveraging Scale for Value initiative in March to collaborate as a system to reduce costs and enhance revenue at UC medical centers.

At the Moore Foundation, DiGiorgio developed and managed multiple systemwide health care grants in the Bay Area and greater Sacramento regions — many of which resulted in significant reductions in patient morbidity and mortality and led to improvements in patient care. Previously, she worked as the R.N. discharge coordinator and a staff/charge nurse in the emergency department at UCSF Medical Center. She is a graduate of Georgetown University and holds an M.S.N. in health policy from UC San Francisco and an M.S. from Drexel University in Philadelphia.

The Center for Health Quality and Innovation is governed by a board composed of the six UC medical school deans, five UC medical center CEOs and chaired by the UC Health senior vice president.

CATEGORY: NewsComments (1)

UCSF Medical Center, John Muir Health to collaborate


Affiliation would be cornerstone of regional network offering high-quality, affordable care.

UCSF Medical Center and John Muir Health have signed a letter of intent to develop a company that will serve as the cornerstone of a Bay Area health care network intended to provide patients with high-quality care and an exceptional experience at an affordable price. A final agreement is expected by the end of 2014.

Under the proposed agreement both organizations would remain independent, but a new company would be created that is equally owned and operated by both organizations. The new company would serve as a funding vehicle for future joint initiatives and a shared services organization to support programs and initiatives focused on better health care, at lower costs, for Bay Area patients.

The first of these joint initiatives is investment in a collaborative effort with other health care providers to form a regional health care network, or “accountable care organization” (ACO). Establishing a Bay Area-wide ACO will provide patients from throughout the Bay Area and Northern California with a competitively priced option to access, close to where they live or work, many of the Bay Area’s most trusted and respected hospitals, health systems and physician organizations.

Both John Muir Health and UCSF Medical Center have experience in successful ACOs that have demonstrated lower health care costs and improved health care quality. The goal of an ACO is to provide the right care at the right time and in the most appropriate setting, whether that is the primary care physician’s office, an outpatient center or a hospital, and savings achieved as part of an ACO can be passed along to consumers in the form of lower health care benefit premiums.

“By combining John Muir Health and UCSF’s strengths, we aim to offer patients the highest value system of care available,” said Mark R. Laret, CEO of UCSF Medical Center and UCSF Benioff Children’s Hospitals. “We look forward to working not just with each other, but with other health organizations throughout Northern California, in order to provide an exceptional health care experience for patients.”

“The jointly owned and operated company brings together two organizations that share a commitment to providing patients with high-quality care at an affordable price,” said Cal Knight, President and CEO of John Muir Health. “We looked at a number of affiliation options that would allow us to grow without compromising our mission, vision and independence. We found the right fit with UCSF and look forward to the development, along with other partners, of a regional ACO that will benefit patients and the communities we serve.”

Read more

For more health news, visit UC Health, subscribe by email or follow us on Flipboard.

CATEGORY: NewsComments Off

UCSF names chair of bioengineering and therapeutic sciences


Tejal Desai’s appointment begins Aug. 1.

Tejal Desai, UC San Francisco

Tejal Desai, Ph.D., has been named the new chair of the Department of Bioengineering and Therapeutic Sciences (BTS), a joint department within the UC San Francisco School of Pharmacy and School of Medicine. Her appointment is effective Aug. 1.

“I am delighted Tejal will chair the Department of Bioengineering and Therapeutic Sciences,” said Chancellor Sam Hawgood, M.B.B.S., who is also serving as School of Medicine dean. “She has the vision, energy and experience that will ensure the department continues to thrive.”

“Tejal’s willingness to serve as department chair is characteristic of her collegial approach to science and education,” added School of Pharmacy Dean B. Joseph Guglielmo, Pharm.D. “She is an award-winning bioengineer and an accomplished teacher and administrator who has the deep respect of the faculty.  I’m very pleased Tejal has accepted the chair position.”

Desai replaces Kathy Giacomini, Ph.D., who stepped down to lead the UCSF-Stanford FDA Center of Excellence in Regulatory Science and Innovation (CERSI), a joint venture with Stanford University. The U.S. Food and Drug Administration (FDA) provided the funding for CERSI.

“Building upon her spectacular success with the creation of the Department of Bioengineering and Therapeutic Sciences with past co-chair Sarah Nelson, Ph.D., Kathy’s contributions to CERSI will be equally distinguished in the coming years,” Guglielmo said.

Prior to her appointment, Desai was vice chair in the Department of Bioengineering and Therapeutic Sciences.

“This is a unique department, not only at UCSF, but also internationally,” Desai said. “We have talented and diverse faculty members who aren’t afraid to take risks and work at the new intersection of pharmacy, medicine, engineering and basic science.  As chair, I hope to further strengthen the department, support and advocate for the faculty, and ensure the department’s continued success so it can be a model worldwide.”

Read more

 

CATEGORY: NewsComments Off

Regents confirm San Hawgood as UCSF chancellor


He is 10th chancellor of the health sciences campus.

UC President Janet Napolitano shakes the hand of the newly confirmed UCSF Chancellor Sam Hawgood at a press briefing after the Board of Regents approved his appointment on July 17. (Photo by Cindy Chew)

The University of California Board of Regents today (July 17) approved Sam Hawgood as the 10th chancellor of UC San Francisco, where he has served as dean of the UCSF School of Medicine and interim chancellor.

Hawgood, 61, was selected by President Janet Napolitano as the next chancellor after he rose to the top of a strong field of candidates. A search committee composed of regents, faculty, alumni, staff and students reviewed more than 375 candidates and interviewed seven finalists for the position.

“Dr. Hawgood’s list of accomplishments in the lab, in the clinic and in the administrative suite is long and illustrious,” said Regents Chairman Bruce D. Varner.

“Throughout a truly exhaustive selection process, Dr. Hawgood demonstrated the intellectual inquisitiveness, leadership acumen and powerful vision we seek in our chancellors,” Napolitano said. “When an exhaustive search lands on a candidate from within the institution, it is a sign that the enterprise is fundamentally robust. We have been fortunate to have Sam as a member of the UC family for more than 30 years.”

Hawgood had served as interim chancellor since Susan Desmond-Hellmann stepped down April 1, 2014, to become chief executive officer of the Bill & Melinda Gates Foundation.

UCSF, with an annual budget of $4.2 billion, includes nationally top-ranked graduate schools of medicine, dentistry, nursing and pharmacy, as well as affiliated hospitals, a pre-eminent biomedical research enterprise and a graduate division with nationally renowned programs in basic, biomedical, translational and population sciences.

“I understand and deeply respect the core values of UCSF – and both the principle and practice of shared governance with the faculty,” Hawgood told the regents after they approved his appointment.

“But I know that, while we should remain connected to our past and preserve our values,” he said, “our times call for a rigorous look at the reality of the world today and a willingness to move forward in new directions. I embrace the opportunity to work closely with the faculty as we embark, together, on this journey.”

The Board of Regents approved a state-funded base salary of $500,000, plus $250,000 to be funded through an endowed chair, The Arthur Rock and Toni Rembe Distinguished Professorship, created specifically for the chancellor position by the UCSF Foundation, using no state funds.  His total cash compensation ranks 34th among chancellors and presidents of the 62 public research universities that are part of the Association of American Universities.

Consistent with past practice, Hawgood will receive an annual auto allowance of $8,916, and the university will provide him with the existing UCSF Chancellor’s home, which is suitable for duties such as fundraising. The residence is maintained with non-state funds.

With 22,800 faculty and staff, UCSF is the second-largest employer in San Francisco, and generates more than 17,000 additional jobs locally through its construction, its expenditures and purchases by employees, students and visitors.

Hawgood has served as dean of the UCSF School of Medicine and as vice chancellor for medical affairs since September 2009, after assuming the role of interim dean in December 2007. He previously had chaired the Department of Pediatrics, having first served in an interim role. He also served as associate director of the Cardiovascular Research Institute.

The School of Medicine has an operating budget of more than $1.9 billion, 7,400 faculty and staff, and about 3,655 medical and graduate students, residents, fellows and postdoctoral scholars. The school’s clinical faculty is known widely for world-class medical care through its practice in the top-ranked UCSF Medical Center, UCSF Benioff Children’s Hospital, San Francisco (newly affiliated with Children’s Hospital Oakland, now known as UCSF Benioff Children’s Hospital, Oakland), Langley Porter Psychiatric Institute, San Francisco General Hospital & Trauma Center, and the San Francisco Veterans’ Administration Medical Center.

Under Hawgood’s leadership, the school became the top medical school in the nation in research funding from the National Institutes of Health ($439.6 million in 2013), with many of its departments also leading the nation in their fields. It also became the only medical school in the nation to rank in the top five in both research and primary-care education, in the U.S. News & World Report’s annual assessment of graduate schools.

Numerous organizations and publications have recognized Hawgood’s scientific contributions. He is past president of the Society for Pediatric Research and a member of the American Association of Physicians, and in 2010 was elected to the Institute of Medicine (IOM), which provides authoritative advice to Congress, other decision makers and the public as part of the National Academy of Sciences. Membership in the IOM is one of the highest honors for individuals at the top of their fields.

“Curiosity-driven basic science is and will remain the jewel in the UCSF crown,” Hawgood said, “but two realities must be faced. The first is funding.  Federal funding in basic research and development is flat with declining purchasing power. I am committed to doing everything possible to strengthen basic research at UCSF.

“The second is the merging of technologic and biologic sciences in ways unimagined only a few years ago. Both these trends in the research sector suggest innovative public-public and public-private partnerships are needed as well as new routes to commercialization.”

UCSF research has led to revolutions in health and therapeutics, from the birth of the field of biotechnology and first therapies for HIV/AIDS to clinical innovations such as fetal surgery and stem cell therapies offering the promise of transforming lives worldwide. The faculty includes five Nobel laureates, who have made seminal contributions to advance the understanding of cancer, neurogenerative diseases, aging and stem cell research.

Hawgood has been active for decades in clinical medicine. He served as division chief of the Division of Neonatology, then as chair of Pediatrics and physician-in-chief of the UCSF Benioff Children’s Hospital before becoming dean. He has been serving as president of the UCSF Medical Group, the faculty association that represents more than 1,800 UCSF physicians.

He joined UCSF as a research fellow in 1982, working with distinguished scientists John A. Clements, M.D., and William H. Tooley, M.D., both pioneers in the discovery and therapeutic uses of pulmonary surfactant, the key lipoprotein that lines healthy lungs and enables them to expand with each breath. He has maintained his own laboratory since 1984. His research has gained him an international reputation in neonatology research.

A native of Australia, Hawgood entered medical school at the age of 17, and was graduated with First Class Honors from the University of Queensland in Brisbane with a degree in medicine and surgery (M.B.B.S.).

Hawgood and his wife, Jane, a social worker who recently retired after focusing on palliative care for adults, met at the University of Queensland. They have two grown sons.

Related link:
UCSF coverage

CATEGORY: NewsComments Off

UC Health appoints interim supply chain executive


UC Davis’ Vincent Johnson to lead systemwide supply chain efforts.

Vincent Johnson

The University of California has appointed Vincent Johnson, chief operating officer of UC Davis Medical Center, as interim UC Health systemwide supply chain executive.

For fiscal year 2015, Johnson will be responsible for the leadership and success of the joint UC medical centers’ systemwide procurement strategies and programs, as part of the “Leveraging Scale for Value” project to reduce costs at UC hospitals.

Advancing health care reform will require UC’s medical centers to operate more efficiently. UC medical centers recognize this challenge and have embarked upon an aggressive program to apply the integrated scale of UC to adapt to increasing resource and financial challenges.

UC’s Leveraging Scale for Value project, announced in March, initially will focus on three areas: supply chain, revenue cycle and clinical laboratories. This effort is governed by the UC Health Shared Services Management Council, which consists of the five UC medical center CEOs, three medical school deans, two chancellors, one regent, three external experts and is chaired by UC Health Senior Vice President John Stobo.

Increasing systemwide leverage in supply chain is among the first efforts launched by the council to rapidly reduce operating expenses through aggressive procurement savings. Focusing initially on non-medical supplies, purchased services and capital procurement, UC plans to find savings through increasingly coordinated procurement. Medical supply savings also will be sought out with appropriate clinical support.

Johnson will lead this effort and report directly to the council. He will be supported by UC San Francisco Medical Center Chief Operating Officer and Supply Chain Vice Chair Ken Jones and the UC medical centers’ supply chain leadership team. Their savings target for fiscal year 2015 will be in excess of $50 million.

To accomplish these savings, Johnson and his teams will focus on working directly with UC’s supply and service vendors to reduce expenses through systemwide procurement leverage, infrastructure development and operating efficiencies.

Future supply chain improvement efforts will advance UC’s competitiveness through transformative programs built upon these initial systemwide savings efforts.

Related links:

CATEGORY: NewsComments Off

President Napolitano selects UCSF chancellor


Sam Hawgood’s selection will be voted on July 17 by UC Regents.

Sam Hawgood has been tapped to become UC San Francisco's 10th chancellor. (Photo by Elisabeth Fall)

University of California President Janet Napolitano announced today (July 9) that her choice for the 10th chancellor of UC San Francisco is Sam Hawgood, the UCSF School of Medicine dean who emerged from a national search as the top candidate after leading the campus in an interim role.

Hawgood, 61, a highly accomplished scientist, educator and physician with a strong record of leadership, succeeded Susan Desmond-Hellmann as interim chancellor on April 1, 2014. Since then, he has overseen the $4 billion UCSF enterprise, which, in addition to the renowned medical school, includes nationally top-ranked schools of dentistry, nursing and pharmacy, as well as a graduate division and affiliated hospitals.

The UC Board of Regents will vote on Napolitano’s selection and the terms of the appointment on July 17 in a special session at the conclusion of the regents’ regular bimonthly meeting.

“Sam Hawgood has served UC San Francisco exceedingly well for three decades — as a researcher, physician and leader,” Napolitano said. “As interim chancellor, he has advanced initiatives in both basic and clinical science, as well as precision medicine.

“He has demonstrated,” she said, “that he possesses the mix of vision, curiosity and empathy essential to the dynamic leadership required to move this already stellar UC institution to even greater heights. When a rigorous, far-reaching search lands on a candidate from within, it demonstrates the fundamental strength of the institution.”

As dean of the School of Medicine, Hawgood has led an organization with an operating budget of more than $1.7 billion, nearly 8,000 faculty and staff, and about 3,655 medical and graduate students, residents, fellows and postdoctoral scholars.

Under his leadership, the school became the top medical school in the nation in research funding from the National Institutes of Health ($439.6 million in 2013), with many of its departments also leading the nation in their fields. In that time, the school also became the only medical school in the nation to rank in the top five in both research and primary-care education, in the U.S. News & World Report’s annual assessment of graduate schools.

The school’s clinical faculty is known widely for world-class medical care through its practice in the top-ranked UCSF Medical Center, UCSF Benioff Children’s Hospital (newly merged with Children’s Hospital Oakland), Langley Porter Psychiatric Institute, San Francisco General Hospital & Trauma Center, and the San Francisco Veterans’ Administration Medical Center.

Hawgood has served as dean of the UCSF School of Medicine and as vice chancellor for medical affairs since September 2009, after assuming the role of interim dean in December 2007. He previously had chaired the Department of Pediatrics, having first served in an interim role. He also served as associate director of the Cardiovascular Research Institute.

Numerous organizations and publications have recognized Hawgood’s scientific contributions. He is a member of the American Academy of Pediatrics and the American Association of Physicians, and in 2010 was elected to the Institute of Medicine (IOM), which provides authoritative advice to Congress, other decision makers and the public as part of the National Academy of Sciences. Membership in the IOM is one of the highest honors for individuals at the top of their fields.

“I am honored, excited and humbled,” Hawgood said, “by the opportunity to lead UC San Francisco to new horizons in basic and clinical research, teaching and patient care, building on a shared vision of this world-class institution’s excellence, history and legacy.

“I look forward to working with all members of the UCSF community — students, faculty and staff, our philanthropic partners and the larger community — as we focus on strengthening every aspect of this great institution,” he said.

Hawgood has been active for decades in clinical medicine. He served as division chief of the Division of Neonatology, then as chair of Pediatrics and physician-in-chief of the UCSF Benioff Children’s Hospital before becoming dean. He is the president of the UCSF Medical Group, the faculty association that represents more than 1,800 UCSF physicians.

“Dr. Hawgood knows how to engage in shared governance with all segments of the faculty, and he understands every aspect of our central mission that relates to research, education and public service,” said Farid F. Chehab, Ph.D., a professor in the Department of Laboratory Medicine and chair of the UCSF Academic Senate. “He has done a terrific job as dean of the School of Medicine, and always looks at the larger picture without overlooking any of the details. I think his leadership as chancellor will take UCSF to new heights and positively impact on faculty, staff and students.”

Hawgood joined UCSF as a research fellow in 1982, working with distinguished scientists John A. Clements, M.D., and William H. Tooley, M.D., both pioneers in the discovery and therapeutic uses of pulmonary surfactant, the key lipoprotein that lines healthy lungs and enables them to expand with each breath. He has maintained his own laboratory since 1984. His research has gained him an international reputation in neonatology research.

“The search to fill the chancellorship was national in scope, and the field of candidates was impressive,” UC Board of Regents Chairman Bruce D. Varner said. “No candidate was more impressive, however, than Dr. Hawgood, who made clear to members of the search committee that his passion for UCSF was matched only by his preparedness to lead it forward. I look forward to taking up Sam’s nomination when the Board of Regents meets.”

A native of Australia, Hawgood entered medical school at the age of 17, and was graduated with First Class Honors from the University of Queensland in Brisbane with a degree in medicine and surgery (MBBS).

Hawgood and his wife, Jane, a social worker who recently retired after focusing on palliative care for adults, met at the University of Queensland. They have two grown sons.

“With his incredible credentials, experience and intimate knowledge of every aspect of the campus, Sam Hawgood is the logical and ideal choice to be the next chancellor of UC San Francisco,” said William E. Oberndorf, chair of the UC San Francisco Foundation Board of Directors.

“He has served the university in many capacities, and he is well known to many of our most important donors,” Oberndorf said. “His leadership qualities and the continuity of service will enable UC San Francisco to move forward without losing a step as we forge new paths in research and clinical care.”

The members of the search advisory committee for the UCSF chancellor included five regents; representatives of UC faculty, including the Academic Senate, the UCSF Medical Center and UCSF Foundation; and staff, students and alumni. Napolitano and Varner were ex officio members.

The search advisory committee was involved in recruiting, screening and conducting interviews with candidates for the position. The committee reviewed more than 375 prospective candidates and conducted in-depth interviews with seven finalists. The search was assisted by the executive search firm Isaacson, Miller.

“Sam Hawgood brings integrity, intellect and vision to UC San Francisco,” said Susan Desmond-Hellmann, the chief executive officer of the Bill & Melinda Gates Foundation who served as UC San Francisco chancellor from Aug. 3, 2009, until April 1, 2014. “He is one of the best leaders I ever worked with. The university will be in great hands with Sam leading the way.”

(NOTE TO NEWS MEDIA: Neither President Napolitano nor Dr. Hawgood will comment further until the regents have acted on the proposed appointment.)

CATEGORY: NewsComments Off

UC Davis names chief of trauma surgery


Joseph Galante selected.

Joseph Galante, UC Davis

Joseph Galante has been named chief of the UC Davis Division of Trauma, Surgical Critical Care and Acute Care Surgery. He previously served as the division’s trauma medical director and interim chief, in addition to serving as vice chair for education and director of the general surgery residency program for the Department of Surgery.

Galante is a fellow of the American College of Surgeons and a member of the American Association for the Surgery of Trauma. After receiving his medical degree from Temple University, he received his general surgical training and completed his trauma and critical care fellowship at UC Davis, where he received the Outstanding Chief Resident Award. In 2012, he was named by the Sacramento Business Journal as one of its “40 under 40,” an annual recognition of up-and-coming professionals who have made important community contributions. He also received the Department of Surgery Outstanding Faculty Teaching Award in 2013.

In addition to his work at UC Davis, Galante is a member of the U.S. Naval reserves who has served with distinction both in the U.S., Western Pacific and Afghanistan. His research focuses on improving medical treatment in response to disasters and utilizing military medical technology to benefit civilian practice. As a teacher and mentor, he is training health-care providers who treat those in the armed forces. Among his many military honors are the Navy Commendation Medal, three Navy and Marine Corps Achievement medals and the Military Outstanding Volunteer Service Medal.

Galante has served as a team physician to the FBI SWAT team in Sacramento and as a physician member of the disaster medical assistance team in the California region of the Federal Emergency Management Agency.

View original article

CATEGORY: NewsComments Off

UC San Diego appoints pharmacy school dean


James McKerrow will become school’s second dean.

James McKerrow

Effective July 1, 2014, James H. McKerrow, M.D., Ph.D., will become the second dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego. McKerrow will join UC San Diego from UC San Francisco, where he served as professor of pathology and director of the Center for Discovery and Innovation in Parasitic Diseases.

An expert in the area of neglected tropical diseases, McKerrow brings a wealth of experience in natural product research and drug discovery and development. His keen interest in these areas will help bring together cross-disciplinary researchers at UC San Diego and in the community – in global health, infectious diseases, biology and chemistry and drug development programs – all of which are of strategic importance to the health sciences and the UC San Diego campus.

McKerrow is an alumnus of UC San Diego, where he earned his Ph.D. in biology in 1973, focusing on peptide chemistry and molecular genetics. He then went on to receive his M.D. from SUNY, Stony Brook with an internship in internal medicine. He completed his residency in pathology at UCSF, where he was chief resident from 1979 to 1980. From 1980 to 1981, he continued at UCSF as a postdoctoral fellow and clinical instructor, moving on to become an assistant (1981-87), associate (1987-93) and full professor (1993-present) in the Department of Pathology. From 2003 to 2012, he also served as vice chair for research and education in the Department of Pathology.

He is an active teacher and mentor in graduate and postdoctoral programs, lectures to medical and health profession students and has hosted underrepresented students each year for summer research internships. Committed to fostering science education in the community, he gives talks each year to elementary and high school students, and has presented three public lectures in the “Ask a Scientist” series in San Francisco.

McKerrow has co-authored more than a dozen book chapters, published more than 250 articles and has been a keynote speaker at numerous conferences and symposia. His many honors range from teaching awards spanning more than two decades at UCSF to the Gregor Mendel Honorary Medal from the Academy of Sciences of the Czech Republic and the 2005 Distinguished Alumnus Award from SUNY, Stony Brook.

He is a member of the American Society for Cell Biology, American Society of Microbiology, American Society of Biochemistry and Molecular Biology, American Society of Tropical Medicine and Hygiene, American Society of Parasitologists, and the American Society of Immunologists. He currently serves on the editorial boards of Chemical Biology and Drug Design and PLoS Neglected Tropical Diseases.

In July 2000, the UC Board of Regents approved the establishment of the UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences. The school matriculated the first class of 25 Doctor of Pharmacy (Pharm.D.) students in the fall of 2002. The steady-state enrollment is 240 Pharm.D. students, 60 Ph.D. students and 30 pharmacy residents. The school offers an innovative and flexible curriculum leading to the Doctor of Pharmacy degree, taught by a stellar health sciences faculty in close association with the outstanding clinical, research and academic programs of the UC San Diego School of Medicine.

To learn more about the UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, click here.

View original article

CATEGORY: NewsComments Off

UCLA nursing school names acting dean


Linda Sarna will serve one-year term.

Linda Sarna, UCLA

Professor Linda Sarna, who holds the Lulu Wolf Hassenplug Chair in the UCLA School of Nursing, has been appointed acting dean of the School of Nursing as of July 1, 2014. She will serve a one-year term while Dean Courtney Lyder is on leave.

Sarna served as chair of the UCLA Academic Senate during the 2012–13 academic year, and she chairs the committee that implemented UCLA’s tobacco-free policy.

At UCLA and beyond, Sarna is recognized for her scholarship promoting the role of nursing in tobacco control and for her research on the symptoms and quality of life of people with lung cancer. As the principal investigator for the Tobacco Free Nurses Initiative and through her active involvement in tobacco-control policy efforts nationally and internationally, she has emphasized the need to change expectations for nursing education and clinical practice.

Sarna is the author of more than 200 peer-reviewed articles, books, chapters and other publications. Her numerous honors and awards include election as a fellow to the American Academy of Nursing and recognition as a distinguished research professor by the Oncology Nursing Society.  She has served on commissions and task forces for the National Cancer Institute, the American Society of Clinical Oncology, the Institute of Medicine and the University of California, among others. Sarna received her bachelor’s and master’s degrees in nursing from UCLA, and her doctorate from UC San Francisco.

View original article

CATEGORY: NewsComments Off